GL1X · GenesisL1 explorer

MolNFT v1 · #126892 · protein

Crystal structure of kpc-2 carbapenemase in complex with a phenyl boronic inhibitor.

5MGI · Carbapenem-hydrolyzing beta-lactamase kpc: “Crystal structure of kpc-2 carbapenemase in complex with a phenyl boronic inhibitor.”. X-ray diffraction, 1 ligand (6YV), 1 pocket (best druggability 0.33). MolNFT v1 #126892 on GenesisL1…

PDB
5MGI
Type
protein
Length
264 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Carbapenem-hydrolyzing beta-lactamase kpc
EC
3.5.2.6
UniProt
Q848S6
Ligands
6YV
Pockets
1 · best druggability 0.33

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACarbapenem-hydrolyzing beta-lactamase kpc (EC 3.5.2.6)protein26443% helix, 17% strandQ848S6

Ligands and binding sites

  • 6YV · (~{E})-3-[2-(dihydroxyboranyl)phenyl]prop-2-enoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1920.330.74186YV

Modifications

Observed in the structure: 1 covalent, 1 disulfide (covalent ligand, disulfide).

Compared structures

  • 5MGI · Crystal structure of KPC-2 carbapenemase in complex with a phenyl boronic inhibitor. · the same entry in another collection · chain A against A, TM-score 1.00
  • Q848S6 · AlphaFold monomer V2.0 prediction for carbapenem-hydrolyzing beta- lactamase kpc (Q848S6) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.